✦ LIBER ✦

Dose-ranging Study of the Luteinizing Hormone-releasing Hormone Receptor Antagonist Cetrorelix Pamoate in the Treatment of Patients With Symptomatic Benign Prostatic Hyperplasia

✍ Scribed by Frans Debruyne; Mitko Tzvetkov; Silvio Altarac; Petrisor A. Geavlete

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mechanisms of inhibition of human benign

✍ Agnieszka Siejka; Andrew V. Schally; Norman L. Block; Nektarios Barabutis 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB

Placebo-Controlled Dose-Ranging Phase 2

✍ Frans Debruyne; Arkadij A. Gres; Dmitrii L. Arustamov 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 561 KB

Placebo-Controlled Dose-Ranging Phase 2

✍ Roehrborn, C.G. 📂 Article 📅 2008 🏛 Elsevier Science ⚖ 54 KB

Editorial Comment on: Placebo-Controlled

✍ Vincenzo Ficarra; Giacomo Novara 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Editorial Comment on: Placebo-Controlled

✍ Mark J. Speakman 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Editorial Comment on: Placebo-Controlled

✍ Patrick J. Bastian 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 66 KB